Inactive Instrument

Akumin Inc.

AKUMQ

US01021X1000

Healthcare Facilities & Services

Akumin Inc. Provides Consolidated Earnings Guidance for the Year 2023

May 11, 2023 at 08:30 am EDT

Akumin Inc. provided consolidated earnings guidance for the year 2023. For the year, the company expects consolidated revenues to be in the range of $765 million to $775 million.

Latest news about Akumin Inc.

Akumin Inc. Announces Partnership with Northern Nevada Sierra Medical Center for Radiation Oncology Services	Feb. 21	CI
Akumin Announces CEO Changes	Feb. 08	CI
Akumin Appoints Chandra Westergaard as General Counsel	Feb. 08	CI
Akumin Inc. Emerged from Bankruptcy	Feb. 05	CI
Akumin Inc. cancelled the transaction announced on October 20, 2023	Feb. 05	CI
Akumin Provides Update On Restructuring Transaction, To Delist Stock From TSX	Feb. 01	MT
Akumin CFO Resigns, Interim Replacement Named	Jan. 02	MT
Akumin Inc. Announces Chief Financial Officer Changes	Dec. 29	CI
Akumin Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 12	CI
Pre-Packaged Joint Reorganization Plan and Disclosure Statement Approved for Akumin Inc.	Nov. 30	CI
Final DIP Financing Approved for Akumin Inc.	Nov. 28	CI
Notice for Auction Cancellation Filed by Akumin Inc.	Nov. 10	CI
Bidding Procedure Approved for Akumin Inc.	23-10-27	CI
Akumin Inc.(NasdaqCM:AKU) dropped from S&P TMI Index	23-10-26	CI
S&P Downgrades Akumin Following Bankruptcy Filing	23-10-25	MT
Akumin Inc.(OTCPK:AKUM.Q) dropped from NASDAQ Composite Index	23-10-25	CI
Top Midday Gainers	23-10-23	MT
Wall Street Set to Open Lower Monday as National Activity Index Shows Near-Historic Economic Growth	23-10-23	MT
Investors Await Economic, Inflation Data as US Futures Trend Lower in Monday's Premarket	23-10-23	MT
Top Premarket Gainers	23-10-23	MT
Interim DIP Financing Approved for Akumin Inc.	23-10-23	CI
Disclosure Statement Approved Conditionally for Akumin Inc.	23-10-23	CI
Motion for Joint Administration Approved for Akumin Inc.	23-10-23	CI
Pre-Packaged Joint Reorganization Plan and Disclosure Statement Filed by Akumin Inc.	23-10-22	CI
Motion for Asset Sale Filed by Akumin Inc.	23-10-22	CI

Akumin Inc. is a provider of radiology and oncology services to health systems, hospitals, physician groups, and patients all across the country. The Company operates through two segments: Radiology and Oncology. The Company provides fixed-site outpatient diagnostic imaging services through a network of approximately 180 owned and/or operated imaging locations, and outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across 48 states. Its imaging procedures include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other related procedures. Its cancer care services include a full suite of radiation therapy and related offerings. Its services include radiology exams, radiology technology, radiology subspecialties, oncology conditions treated and oncology radiation therapy.

Sector

Healthcare Facilities & Services

Calendar

2024-08-13 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-23.47%	8.01B
RADNET, INC.	+67.47%	4.3B
DR. LAL PATHLABS LIMITED	+0.32%	2.55B
SYNLAB AG	-8.93%	2.46B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.22%	2.44B
NEOGENOMICS, INC.	-8.65%	1.89B
FLEURY S.A.	-17.46%	1.59B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.70%	1.21B
METROPOLIS HEALTHCARE LIMITED	+13.38%	1.17B

Medical & Diagnostic Laboratories

Akumin Inc.

Equities

AKUMQ

US01021X1000

Healthcare Facilities & Services

Akumin Inc. Provides Consolidated Earnings Guidance for the Year 2023

Latest news about Akumin Inc.

Chart Akumin Inc.

Company Profile

Sector Medical & Diagnostic Laboratories